Evidence map›Paper›PMID 17475671›Full record

ArticleMolecular cancer research : MCR2007

PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.

Karen D Cowden Dahl, Reema Zeineldin, Laurie G Hudson

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Epigenetic regulation of mmp-9 gene expression.Cellular and molecular life sciences : CMLS · 2013
    Review
  13. Article
  14. Article
  15. Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2012
    Review
  16. Article
  17. Molecular mechanisms of MMP9 overexpression and its role in emphysema pathogenesis of Smad3-deficient mice.American journal of physiology. Lung cellular and molecular physiology · 2012
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Karen D Cowden DahlHealth Sciences Center, College of Pharmacy, University of New Mexico, MSC 09 5360, 87131-0001 Albuquerque, NM, USA.
Reema Zeineldin
Laurie G Hudson
University of New Mexico · US

Funding

New Mexico NIEHS CenterP30ES012072 · NIEHS · UNIVERSITY OF NEW MEXICO · PI BURCHIEL, SCOTT WILLIAM · 2003 to 2007
$4.1M
Activated EGF Receptor in Ovarian CancerR01CA090492 · NCI · UNIVERSITY OF NEW MEXICO · PI HUDSON, LAURIE G · 2002 to 2006
$1.5M
EGFR activation of PEA3 and FOXM1 in ovarian cancer invasionF32CA119729 · NCI · UNIVERSITY OF NEW MEXICO · PI COWDEN DAHL, KAREN DENISE · 2006 to 2007
$99k
NCI NIH HHS 1F32CA119729-01NCI NIH HHS F32 CA119729NCI NIH HHS P20 CA888070NCI NIH HHS R01 CA090492NCI NIH HHS R01 CA90429NIEHS NIH HHS P30 ES-012072NIEHS NIH HHS P30 ES012072
6 · The paper itself

Abstract

Elevated expression of the epidermal growth factor (EGF) receptor (EGFR) is detected in human ovarian tumors and is associated with decreased recurrence-free and overall survival. EGFR activation affects tumor progression in part by promoting tumor invasion through the induction of prometastatic matrix metalloproteinases (MMP). PEA3, an ETS family transcription factor, is elevated in advanced and metastatic ovarian cancer and regulates MMPs in various cell types, therefore, we investigated whether PEA3 is required for the EGFR-dependent induction of MMP mRNA. MMP-9 and MMP-14 mRNA levels were selectively increased in response to EGFR activity in ovarian tumor cells. EGFR activation resulted in nuclear accumulation of PEA3 and direct binding of PEA3, but not the related protein ETS-1, to the endogenous MMP-9 and MMP-14 promoters. Furthermore, PEA3 overexpression was sufficient to induce MMP-9 and MMP-14 mRNA, tumor cell migration, and invasion, suggesting that PEA3 is an important contributor to the metastatic phenotype. Additionally, inhibition of PEA3 expression via short interfering RNA reduced the EGF induction of MMP-9 and MMP-14 gene expression by 92% and 50%, respectively, and impaired EGF-stimulated tumor cell invasion. These results suggest that PEA3 is regulated by EGFR and that the elevated PEA3 expression detected in human ovarian cancer may divert cells to a more invasive phenotype by regulating MMP-9 and MMP-14.

Indexed as

Cell Line, TumorCell MovementCell NucleusEpidermal Growth FactorErbB ReceptorsFemaleGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHumansMatrix Metalloproteinase 14Matrix Metalloproteinase 9Neoplasm InvasivenessOvarian NeoplasmsPromoter Regions, GeneticProtein BindingRNA, MessengerEpidermal Growth FactorErbB ReceptorsMatrix Metalloproteinase 14Matrix Metalloproteinase 9RNA, Messengertranscription factor PEA3Transcription Factors

Identifiers

PMID17475671
PMCPMC3621069
OpenAlexW2150808367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.